Course of metabolic syndrome following the biliopancreatic diversion of Larrad.

Background: The authors assessed the effect of Larrad's biliopancreatic diversion (BPD) on the main components of the metabolic syndrome.

Patients And Methods: Plasma concentrations of glucose, insulin, total cholesterol (TC), HDL and LDL cholesterol, triglycerides, LDL/HDL and TC/HDL ratios, and blood pressure and body weight were retrospectively evaluated in 40 patients 3-6, 12, 24 and 60 months after undergoing BPD for morbid obesity with metabolic syndrome.

Results: 3-6 months after BPD, glycemia and insulinemia had normalized in 97.